Electrophysiology - LEADR

Lead EvaluAtion for Defibrillation and Reliability

Dr. Meir Friedman is the Principal Investigator for this trial.  The Next Generation ICD Lead is indicated for the treatment of subjects who have experienced, or are at significant risk of developing, life-threatening ventricular tachyarrhythmias.  The purpose of this study is to assess the safety and efficacy of the Next Generation ICD Lead.

Eligibility Criteria

  • Patient meets current clinical practice guidelines for ICD or CRT-D implantation and will undergo implantation of a Medtronic CRT-D or Medtronic ICD system

Please contact Saskia Robinson at 860-972-2196 or email saskia.robinson@hhchealth.org for more information